Hammerson PLC
27 August 2026
27 August 2026
('Hammerson' or 'the Company')
EMTN Programme: Publication of Supplementary Prospectus
Hammerson plc announces the publication of a supplementary prospectus dated 27 August 2026 (the "Supplementary Prospectus") to the base prospectus (the "Base Prospectus") relating to the £5,000,000,000 Euro Medium Term Note Programme under which Hammerson plc is an issuer. The Supplementary Prospectus has been approved by the Financial Conduct Authority and has been published.
A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at and can be downloaded from:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
and
https://www.hammerson.com/investors/debt-investors
For further information:
Hammerson Investor Contacts
Josh Warren, Director of Group Performance and Investor Relations
T: +44 (0) 20 7887 1053 E: josh.warren@hammerson.com
Tom Gough, Head of Communications
T: +44 (0) 20 7887 1092 E: corp.comms@hammerson.com
MHP for Hammerson Media
Ollie Hoare and Charles Hirst
T: +44 (0)20 3128 8100 E: Hammerson@mhpgroup.com
DISCLAIMER - INTENDED ADDRESSEES
EU MiFID II professionals/ECPs only/No EEA PRIIPs KID
UK MiFIR professionals/ECPs only/No DISC disclosure document
This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.
In particular, neither this announcement nor the Supplementary Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.
The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and are subject to Unites States tax law requirements. Subject to certain exceptions, the securities referred to herein may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act). The Supplementary Prospectus and the Base Prospectus may not be accessed from, or transmitted in or into, the United States. Accordingly, these securities may not be offered, sold or delivered in the United States.
Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus, you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirements.
This announcement has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.